Here are the 424B prospectus supplements from Lazard, Inc. (LAZ) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow LAZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LAZ filings page.
Lazard, Inc. registered for resale by the selling stockholders up to 9,416,817 shares of common stock; Lazard is not selling shares and will receive no proceeds from their sales. The selling stockholders decide when and how to sell, subject to contractual transfer restrictions, and may sell some, all or none of the shares.
The resale shares were issued as consideration in Lazard’s completed acquisition of Campbell Lutyens on November 1, 2026. At closing, Lazard issued 9,651,777 shares as initial consideration and paid approximately $93.2 million in cash. Of the 9,416,817 shares registered for resale, 2,955,669 are subject to contractual lock-ups that lapse in installments on November 1, 2027, November 1, 2028 and November 1, 2029; 6,461,148 are not subject to those lock-ups.